Evidence map›Paper›PMID 39538014›Full record

ArticleNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2025

Chronic Δ

Brian D Kangas, Harshawardhan U Deshpande, Sarah L Withey, Roger D Spealman, Jack Bergman, Stephen J Kohut

Abstract read
In one paragraph

Article in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Chronic ΔBritish journal of pharmacology · 2025
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Brian D KangasHarvard Medical School, McLean Hospital, Belmont, MA, 02478, USA. bkangas@mclean.harvard.edu.ORCID http://orcid.org/0000-0002-4597-9801
Harshawardhan U DeshpandeHarvard Medical School, McLean Hospital, Belmont, MA, 02478, USA.
Sarah L WitheyHarvard Medical School, McLean Hospital, Belmont, MA, 02478, USA.
Roger D SpealmanHarvard Medical School, McLean Hospital, Belmont, MA, 02478, USA.
Jack BergmanHarvard Medical School, McLean Hospital, Belmont, MA, 02478, USA.
Stephen J KohutHarvard Medical School, McLean Hospital, Belmont, MA, 02478, USA.ORCID http://orcid.org/0000-0002-6906-8818

Funding

Neural, Cognitive and Abuse-Related Consequences of Chronic THC Exposure during Adolescence in Nonhuman PrimatesR01DA047575 · NIDA · MCLEAN HOSPITAL · PI JACK BERGMAN, Brian D. Kangas · 2019 to 2026
$5.7M
NIDA NIH HHS R01 DA047575U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse (NIDA) R01-DA047575
6 · The paper itself

Abstract

Although chronic cannabis use during adolescence can alter brain function and impair complex behavioral processes, it is unclear whether such deficits persist into adulthood. Using a coordinated awake neuroimaging and behavioral approach in nonhuman primates, we addressed this issue by examining the impact of chronic adolescent exposure to Δ

Indexed as

BrainDronabinolMotivationAnimalsFemaleMagnetic Resonance ImagingMaleNeural PathwaysRewardSaimiriDronabinol

Identifiers

PMID39538014
PMCPMC11735839

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.